The Company will not receive any proceeds of the Offer for Sale by the Selling Shareholder. (up to 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd, up to 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Ltd, up to 3,573,014 equity shares by Empower Discretionary Trust and up to 1,874,500...
Established in Hyderabad in 1978, Gland Pharma is one of the largest and fastest growing injectable-focused B2B companies, with a global footprint across 60 countries, including the US, Europe, Canada, Australia, India and other markets. It is a niche player in sterile injectables, oncology and ophthalmic solutions with focus on first-to-file, 505(b)(2) filings and NCE- 1s. Along with its partners Gland has 267 ANDA filings (101 owned) in the US as of Q1FY21, of which 215 were approved. The company has seven manufacturing facilities in India, comprising four formulations facilities with...
On the back of rebound in economic activities, cargo volume bounced back and registered a growth of 36% on a QoQ basis and 7% on a YoY basis. All segments of cargo registered growth on a QoQ basis. While coal registered 30% growth, container grew by 34%, crude by 52% and other bulk cargo registered a growth of 40%....
The Promoter of Equitas Small Finance Bank (ESFB) i.e. Equitas Holdings Limited (EHL) was granted the RBI Final Approval on June 30, 2016, to establish a Small Finance Bank (SFB). Subsequently, the Bank was converted to a SFB and it commenced operations on September 05, 2016. Market outlook and valuation: At the upper end
